Schroder Investment Management Group’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $4.84M | Buy |
|
|||||
|
2025
Q2 | $2.8M | Sell |
|
|||||
|
2025
Q1 | $7.46M | Buy |
|
|||||
|
2024
Q4 | $5.48M | Sell |
|
|||||
|
2024
Q3 | $13M | Sell |
|
|||||
|
2024
Q2 | $13.8M | Sell |
|
|||||
|
2024
Q1 | $13.3M | Buy |
|
|||||
|
2023
Q4 | $8.51M | Buy |
|
|||||
|
2023
Q3 | $1.36M | Sell |
|
|||||
|
2023
Q2 | $1.56M | Sell |
|
|||||
|
2023
Q1 | $1.78M | Buy |
|
|||||
|
2022
Q4 | $2.02M | Sell |
|
|||||
|
2022
Q3 | $1.82M | Sell |
|
|||||
|
2022
Q2 | $1.57M | Buy |
|
|||||
|
2022
Q1 | $1.64M | Buy |
|
|||||
|
2021
Q4 | $968K | Buy |
|
|||||
|
2021
Q3 | $935K | Buy |
|
|||||
|
2021
Q2 | $789K | Buy |
|
|||||
|
2021
Q1 | $529K | Hold |
|
|||||
|
2020
Q4 | $487K | Hold |
|
|||||
|
2020
Q3 | $508K | Buy |
|
|||||
|
2020
Q2 | $524K | Buy |
|
|||||
|
2020
Q1 | $225K | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $409K | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $1.81M | Hold |
|
|||||
|
2017
Q1 | $1.17M | Buy |
|
|||||
|
2016
Q4 | $491K | Sell |
|
|||||
|
2016
Q3 | $1.26M | Hold |
|
|||||
|
2016
Q2 | $1.03M | Buy |
|
|||||
|
2016
Q1 | $328K | Hold |
|
|||||
|
2015
Q4 | $522K | Hold |
|
|||||
|
2015
Q3 | $446K | Hold |
|
|||||
|
2015
Q2 | $634K | Sell |
|
|||||
|
2015
Q1 | $1.29M | Hold |
|
|||||
|
2014
Q4 | $1.2M | Sell |
|
|||||
|
2014
Q3 | $1.81M | Buy |
|
|||||
|
2014
Q2 | $1.44M | Buy |
|
|||||
|
2014
Q1 | $1.08M | Sell |
|
|||||
|
2013
Q4 | $1.4M | Sell |
|
|||||
|
2013
Q3 | $1.64M | Sell |
|
|||||
|
2013
Q2 | $958K | Buy |
|